1. Home
  2. FLXS vs PROK Comparison

FLXS vs PROK Comparison

Compare FLXS & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexsteel Industries Inc.

FLXS

Flexsteel Industries Inc.

N/A

Current Price

$85.12

Market Cap

327.6M

ML Signal

N/A

Logo ProKidney Corp.

PROK

ProKidney Corp.

N/A

Current Price

$1.70

Market Cap

316.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FLXS
PROK
Founded
2001
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
327.6M
316.0M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
FLXS
PROK
Price
$85.12
$1.70
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
★ $70.50
$6.25
AVG Volume (30 Days)
74.2K
★ 1.2M
Earning Date
10-19-2026
11-09-2026
Dividend Yield
★ 1.18%
N/A
EPS Growth
★ 70.99
N/A
EPS
★ 6.07
N/A
Revenue
★ $459,178,000.00
$893,000.00
Revenue This Year
$3.60
N/A
Revenue Next Year
$4.64
$7.83
P/E Ratio
$14.18
★ N/A
Revenue Growth
4.10
★ 1075.00
52 Week Low
$34.00
$1.30
52 Week High
$90.65
$3.48

Technical Indicators

Market Signals
Indicator
FLXS
PROK
Relative Strength Index (RSI) 55.57 44.50
Support Level $78.03 $1.56
Resistance Level $84.99 $1.97
Average True Range (ATR) 2.86 0.11
MACD -0.01 -0.03
Stochastic Oscillator 53.69 22.73

Price Performance

Historical Comparison
FLXS
PROK

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Share on Social Networks: